Article preview from Start-Up - December, 2012
Transcutaneous electrical nerve stimulation technology has been used for decades to noninvasively treat acute and chronic pain in the muscles, joints, back, and neck. Now, InControl Medical LLC is employing it in the form of an intravaginal probe combined with patient biofeedback and quantitative physician feedback to treat one of the largest and fastest growing female health care problems, stress and mixed urinary incontinence.
InControl Medical LLC
Article preview from Start-Up - December, 2012
Transcutaneous electrical nerve stimulation (TENS) technology has been used for nearly 40 years to noninvasively and with low risk treat acute and chronic pain in the muscles, joints, back, and neck. Among other indications, it has also been used to stimulate the pelvic floor muscles to treat urinary problems such as overactive bladder and various forms of incontinence. And now, this strategy is being employed in the form of an intravaginal probe combined with patient biofeedback and quantitative physician feedback to treat one of the largest and fastest growing female health care problems, stress and mixed urinary incontinence. Wisconsin-based start-up InControl Medical LLC launched its InTone electronic nerve stimulation device in mid-2012, and the company says its sales are growing rapidly.
The company is led by Hershel "Buzz" Peddicord, who has had a 35-year career in the medical device industry. He served in executive roles at cardiac pacemaker company Biotronik and patient monitoring company Criticare Systems Inc., before founding HomMed LLC, a provider of home health telemonitoring equipment, in 1999. HomMed did well in just a five-year time span, and it was acquired by the Fortune 100 company Honeywell International Inc. in 2004 for $128 million. In 2005, Peddicord was looking for his next entrepreneurial opportunity, and his mother gave him the idea for developing a non-surgical device to help the millions of women who suffer from urinary incontinence. The InTone electronic nerve stimulation device was developed and designed in 2008 by Peddicord and a team of engineers, based on the principle that poor muscle tone in the pelvic floor muscles caused by childbirth, trauma, lack of exercise, and other factors is most often the root cause of incontinence. Once Peddicord had developed a workable prototype via the engineers and suppliers in the Midwest, he secured a round of funding from undisclosed angel investors and launched InControl Medical in August 2010. He also brought aboard some key team members from his previous company, HomMed.
Continued...
To read this article in its entirety, purchase now as a PDF and receive it immediately via email. Or get it FREE when you subscribe to Start-Up.
About Start-Up
No publication reviews leading edge companies and technology better than Start-Up. Each issue of Start-Up profiles the most important new product companies, identifies the hottest technology areas, reviews funds flowing into private companies and investment trends, and reports on university tech transfer licensing. Industries covered: pharmaceuticals, biotechnology, medical equipment & devices, and in vitro diagnostics.
Plus:
To find out about more about more about Elsevier Business Intelligence's medical device publications and databases, multi-user access and/or advertising with Medical Devices Today, please contact Kristy Kennedy at (480) 985-9512





Comments